Evidence map›Paper›PMID 40176267›Full record

ArticleRespirology (Carlton, Vic.)2025

Enhancing Interstitial Lung Disease Diagnoses Through Multimodal AI Integration of Histopathological and CT Image Data.

Kris Lami, Mutsumi Ozasa, Xiangqian Che, Wataru Uegami, Yoshihiro Kato, Yoshiaki Zaizen, Naoko Tsuyama, Ichiro Mori, Shin Ichihara, Han-Seung Yoon and 16 more

Abstract read
In one paragraph

Article in Respirology (Carlton, Vic.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Diagnosis of Lung Diseases in the Artificial Intelligence Era.International journal of molecular sciences · 2026
    Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Kris LamiDepartment of Pathology Informatics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.ORCID 0000-0001-9191-3339
Mutsumi OzasaDepartment of Pathology Informatics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Xiangqian CheStrategic AI Group, Future Corporation, Tokyo, Japan.
Wataru UegamiDepartment of Pathology, Kameda Medical Center, Kamogawa, Japan.
Yoshihiro KatoStrategic AI Group, Future Corporation, Tokyo, Japan.
Yoshiaki ZaizenDivision of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.ORCID 0000-0003-2274-4599
Naoko TsuyamaDivision of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Ichiro MoriDepartment of Pathology, International University of Health and Welfare, Narita, Japan.
Shin IchiharaDepartment of Surgical Pathology, Sapporo Kosei General Hospital, Sapporo, Japan.
Han-Seung YoonDepartment of Pathology Informatics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Ryoko EgashiraDepartment of Radiology, Saga University, Saga, Japan.ORCID 0000-0001-7566-546X
Kensuke KataokaDepartment of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
Takeshi JohkohDepartment of Radiology, Kansai Rosai Hospital, Amagasaki, Japan.
Yasuhiro KondoDepartment of Thoracic Surgery, Kitasato University School of Medicine, Kanagawa, Japan.
Richard AttanoosDepartment of Cellular Pathology, Cardiff University, Cardiff, UK.
Alberto CavazzaPathology Unit, Azienda USL/IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Alberto M MarchevskyDepartment of Pathology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Frank SchneiderDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.
Jaroslaw Wojciech AugustyniakInstitut for Pathology Spandau, Berlin, Germany.
Amna AlmutrafiDepartment of Anatomical Pathology, King Fahad Medical City, Riyadh, Saudi Arabia.
Alexandre Todorovic FabroDepartment of Pathology and Legal Medicine, Ribeirão Preto Medical School University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-7687-3161
Luka BrcicDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Anja C RodenDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Maxwell SmithDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona, USA.
Andre MoreiraDepartment of Pathology, NYU Grossman School of Medicine, New York, New York, USA.
Junya FukuokaDepartment of Pathology Informatics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Funding

Ministry of Health, Labour and WelfareNew Energy and Industrial Technology Development Organization JPNP200006
6 · The paper itself

Abstract

BACKGROUND AND

objectiveThe diagnosis of interstitial lung diseases (ILDs) often relies on the integration of various clinical, radiological, and histopathological data. Achieving high diagnostic accuracy in ILDs, particularly for distinguishing usual interstitial pneumonia (UIP), is challenging and requires a multidisciplinary approach. Therefore, this study aimed to develop a multimodal artificial intelligence (AI) algorithm that combines computed tomography (CT) and histopathological images to improve the accuracy and consistency of UIP diagnosis.

methodsA dataset of CT and pathological images from 324 patients with ILD between 2009 and 2021 was collected. The CT component of the model was trained to identify 28 different radiological features. The pathological counterpart was developed in our previous study. A total of 114 samples were selected and used for testing the multimodal AI model. The performance of the multimodal AI was assessed through comparisons with expert pathologists and general pathologists.

resultsThe developed multimodal AI demonstrated a substantial improvement in distinguishing UIP from non-UIP, achieving an AUC of 0.92. When applied by general pathologists, the diagnostic agreement rate improved significantly, with a post-model κ score of 0.737 compared to 0.273 pre-model integration. Additionally, the diagnostic consensus rate with expert pulmonary pathologists increased from κ scores of 0.278-0.53 to 0.474-0.602 post-model integration. The model also increased diagnostic confidence among general pathologists.

conclusionCombining CT and histopathological images, the multimodal AI algorithm enhances pathologists' diagnostic accuracy, consistency, and confidence in identifying UIP, even in cases where specialised expertise is limited.

Indexed as

Artificial IntelligenceLungLung Diseases, InterstitialTomography, X-Ray ComputedAgedAlgorithmsFemaleHumansMaleMiddle AgedCThistopathologyinterstitial lung diseasemultimodal AIUIP

Identifiers

PMID40176267
PMCPMC12321693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.